Dana T. Aftab
Executive Vice President of Research & DevelopmentDr. Dana T. Aftab, Ph. D., served as Executive VP of Discovery and Translational Research & Chief Scientific Officer at Exelixis, Inc. since December 15, 2022 until August 2025 and is its Executive Vice President of Research and Development since August 2025. He had been Executive Vice President of Business Operations at Exelixis, Inc. from February 2016 to December 2022, during which time he oversaw the company’s corporate site development and campus operations, including the opening of new laboratory buildings at Exelixis’ Alameda campus and the ongoing buildout of the company’s Exelixis East footprint in the Greater Philadelphia area. He has been at Exelixis. Dr. Aftab first joined Exelixis in 1998, starting in Exelixis’ Drug Discovery organization, where he led teams that drove the discovery and development of the company’s approved medicines, including cabozantinib. Dr. Aftab began his tenure with Exelixis in its drug discovery group, where he led the pharmacology department and served as Project Team Leader for discovery programs in oncology and metabolic diseases. In 2007, Dr. Aftab moved into the clinical development organization where he implemented a broad translational medicine platform at the company. He was Senior Vice President, Translational Research from 2009 to 2016. Before joining Exelixis, Dr. Aftab held senior scientist positions at Versicor and Metaxen. He received his Ph. D. pharmacology from Yale University, did postdoctoral work at UC Berkeley in the field of oncogene signaling and completed his B.A. degree at UC Santa Barbara.
Positions
- Company NameExelixis, Inc.Stock CodeEXELPositionExecutive Vice President of Research & DevelopmentColleagues
- SPStelios PapadopoulosCo-Founder & Independent Chair of the Board
- MMMichael M. MorrisseyCEO, President & Director
- CJChristopher J. SennerExecutive VP & CFO
- BJBrenda J. HeftiSenior VP & General Counsel
- JLJack L. WyszomierskiIndependent Director
- JAJulie Anne SmithIndependent Director
- MCMaria C. FreireIndependent Director
